Results 81 to 90 of about 196,190 (245)
Pharmacological Basis of the Clinical Efficacy of Varenicline Used to Facilitate Smoking Cessation
Modern problems caused by the high prevalence of smoking, as well as pharmacological approaches that facilitate quitting smoking are discussed in the review.
S. R. Gilyarevskiy
doaj +1 more source
Smoke-Free Families: State of the Science Capstone Meeting [PDF]
Summarizes research findings on best practices for interventions, policy developments, and future directions discussed at an October 2006 conference of RWJF's Smoke-Free Families: Innovations to Stop Smoking During and Beyond Pregnancy ...
core
GP prescribing of nicotine replacement and bupropion to aid smoking cessation in England and Wales [PDF]
Aims Prescribing nicotine replacement therapy (NRT) or bupropion for smoking cessation is of considerable importance to public health but little is known about prescribing practices.
McEwen, A, Owen, L, West, R
core +1 more source
Key Points Question Compared with standard cessation approaches, can long-term nicotine replacement therapy lead to higher rates of cessation or reductions in carcinogen exposure among smokers with chronic obstructive pulmonary disease?
E. Ellerbeck +8 more
semanticscholar +1 more source
Background and aims Smoking during pregnancy is strongly associated with negative pregnancy and perinatal outcomes. Some guidelines recommend nicotine replacement therapy (NRT) for smoking cessation during pregnancy, but adherence with NRT is generally ...
C. Hickson +8 more
semanticscholar +1 more source
The Use of Web-Based Support Groups Versus Usual Quit-Smoking Care for Men and Women Aged 21-59 Years: Protocol for a Randomized Controlled Trial (Preprint) [PDF]
BACKGROUND Existing smoking cessation treatments are challenged by low engagement and high relapse rates, suggesting the need for more innovative, accessible, and interactive treatment strategies.
Calder, Douglas +4 more
core
Background Evidenced-based tobacco cessation treatments are underused, especially by socioeconomically disadvantaged smokers. This contributes to widening socioeconomic disparities in tobacco-related morbidity and mortality.
S. Fu +9 more
semanticscholar +1 more source
The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients
Background Smoking rates in methadone-maintained patients are almost three times higher than in the general population and remain elevated and stable.
Stohler Rudolf +5 more
doaj +1 more source
Is a combination of varenicline and nicotine patch more effective in helping smokers quit than varenicline alone? A randomised controlled trial [PDF]
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work ...
A McEwen +26 more
core +2 more sources
BackgroundExtended use of combined pharmacotherapies to treat tobacco dependence may increase smoking abstinence; few studies have examined their effectiveness.
H. Tulloch +4 more
semanticscholar +1 more source

